Autoimmune Encephalitis: The bridge between Neurology and Psychiatry
September 21, 2018
The AE Alliance is excited to announce a groundbreaking symposium titled: “Autoimmune Encephalitis: A Bridge Between Neurology and Psychiatry.”
HESA (Hashimoto’s Encephalopathy SREAT Alliance) is the initiator and lead organizer of this symposium to be held on April 6, 2019 at Weill Cornell Medical School, Cornell University in New York, NY.
The April 2019 symposium for doctors and medical students will bring together experts from around the world who are familiar with the troubling fact that autoimmune encephalitis is often misdiagnosed as psychiatric illness due to its presenting symptoms. Speakers include Dr. Josep Dalmau, whose team is credited with discovering Anti NMDA Receptor Encephalitis in 2006, and who remains one of the top experts on this subject. Dr. Maarten Titulaer (the Netherlands) will also be speaking, he is one of the forefront researchers and speakers for autoimmune encephalitis.
The goal of the symposium is to facilitate and enhance the dialogue between the disciplines of neurology and psychiatry, thereby increasing physician recognition of the need to test for AE when a patient presents with abrupt changes in mental status that may include severe depression, anxiety, and even psychosis.
HESA has invited other autoimmune encephalitis, not-for-profit organizations to help organize and promote this important event. In the hope that the fields of neurology and psychiatry(and other specialties) will soon work together to ensure prompt diagnosis and treatment for future autoimmune encephalitis patients. The AE Alliance is excited to be part of this great event!
The event is open to physicians and medical students. For more information and to register, please click here.
